Sverige - svenska - Läkemedelsverket (Medical Products Agency)

merck ab - tegafur; uracil - kapsel, hård - 100 mg/224 mg - tegafur 100 mg aktiv substans; uracil 224 mg aktiv substans; natriumlaurilsulfat hjälpämne - kombinationer

Europeiska unionen - svenska - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - magmuskler - antineoplastiska medel - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.